Roche`S Acquisition of Genentech

Related Essays

Roche's Acquisition Of Gentech
player, growth is realised by mergers and acquisitions (Phizer as example) * Genentechs products are responsible for a big part of Roches total sales (exhibit
Roches Acquisition Of Genentech
February 11, 2011 Dear Valued Scotiabank Customer, In an eort to keep our customers informed, we would like to update you on the Payments Systems Reform process
Case Roche
little progress toward a deal, Humer wondered how he could bring Roches acquisition of Genentech to a successful conclusion. To solve this case we will first look
Risk Manager
The Labor Market Impact of Employer Health Benefit Mandates: Evidence from San Franciscos Health Care Security Ordinance July 6, 2011 Carrie H. Colla*, William H

Submitted by to the category Business and Industry on 05/09/2011 11:23 PM

Case study: Roche's Acquisition of Genentech

1a) Why is Roche seeking to buy the 44% of Genentech it does not own?

Roche is seeking to buy 44% of shares in addition to 56% that already owns. Main purpose of purchasing rest of shares is to merge two companies and exploit the synergies.

Roche owned a majority stake in Genentech from 1990 and since then partnership was considered as one of the most successful in pharmaceutical industry.

Every year less and less invocative products entered the market, so pharmaceutical companies were forced to deliver growth through mergers and acquisitions of other pharmaceutical companies. The old model, where Roche had a majority stake in Genentech but left the company to operate on their own, did not work anymore for Roche, so they decided to do a horizontal acquisition and exploit Genentech potential. Acquisition would bring synergies, reduce risk and grow. The two companies would not be competitive anymore between each other but would increase competitive strength towards other companies. All make sense if the synergies are lower than premium paid.

1b) From Roche's point of view what are advantages of owning 100% of Genentech?

Owning 100% of Genentech would create the largest biotechnology company in the world.

(NY Times: http://www.nytimes.com/2009/03/13/business/worldbusiness/13drugs.html).

Roche would benefit from many of newly established synergies in total value of $5b. The amount is a consequence of manufacturing, development and M&D cost reduction. Government and administration costs would reduce as well.

Complete ownership would enable Roche to have a complete access to all technology, R&D projects and findings held by Genentech. Currently, the conflict of interest with Genentech’s minority shareholders prevent them the access to desired information.

Moreover 100% ownership would enable Roche to extract $9,5b currently held by Genentech in form of cash and cash equivalents. This...

View Full Essay
Full Essay Stats...
  • Words: 3914
  • Pages: 16
  • Views: 2632

Join now to view this essay and thousands of others on PaperCamp.com. It's free Join Now!